237 related articles for article (PubMed ID: 22748655)
1. Potential usefulness of radiosensitizers in glioblastoma.
Harasaki Y; Waziri A
Neurosurg Clin N Am; 2012 Jul; 23(3):429-37. PubMed ID: 22748655
[TBL] [Abstract][Full Text] [Related]
2. Phase II study of concurrent radiation therapy, temozolomide, and bevacizumab followed by bevacizumab/everolimus as first-line treatment for patients with glioblastoma.
Hainsworth JD; Shih KC; Shepard GC; Tillinghast GW; Brinker BT; Spigel DR
Clin Adv Hematol Oncol; 2012 Apr; 10(4):240-6. PubMed ID: 22706484
[TBL] [Abstract][Full Text] [Related]
3. Concomitant chemoradiotherapy followed by adjuvant temozolomide improves survival in glioblastoma multiforme.
Abrey LE
Curr Neurol Neurosci Rep; 2005 May; 5(3):167-8. PubMed ID: 15865881
[No Abstract] [Full Text] [Related]
4. Adults with newly diagnosed high-grade gliomas.
Croteau D; Mikkelsen T
Curr Treat Options Oncol; 2001 Dec; 2(6):507-15. PubMed ID: 12057096
[TBL] [Abstract][Full Text] [Related]
5. A small proportion of glioblastoma patients are probably eligible for concomitant/adjuvant temozolomide.
O'Toole L; Khanduri S; Gerrard GE
Clin Oncol (R Coll Radiol); 2007 May; 19(4):269. PubMed ID: 17433972
[No Abstract] [Full Text] [Related]
6. [Radiotherapy for glioblastomas: from radiobiology to concomitant chemotherapy].
Simon JM; Toubiana T; Lang P; Taillibert S; Mazeron JJ
Cancer Radiother; 2005 Sep; 9(5):322-31. PubMed ID: 16095943
[TBL] [Abstract][Full Text] [Related]
7. Phase I/IIa trial of fractionated radiotherapy, temozolomide, and autologous formalin-fixed tumor vaccine for newly diagnosed glioblastoma.
Ishikawa E; Muragaki Y; Yamamoto T; Maruyama T; Tsuboi K; Ikuta S; Hashimoto K; Uemae Y; Ishihara T; Matsuda M; Matsutani M; Karasawa K; Nakazato Y; Abe T; Ohno T; Matsumura A
J Neurosurg; 2014 Sep; 121(3):543-53. PubMed ID: 24995786
[TBL] [Abstract][Full Text] [Related]
8. Phase I trial of hypofractionated intensity-modulated radiotherapy with temozolomide chemotherapy for patients with newly diagnosed glioblastoma multiforme.
Chen C; Damek D; Gaspar LE; Waziri A; Lillehei K; Kleinschmidt-DeMasters BK; Robischon M; Stuhr K; Rusthoven KE; Kavanagh BD
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1066-74. PubMed ID: 20932651
[TBL] [Abstract][Full Text] [Related]
9. Concomitant and adjuvant temozolomide of newly diagnosed glioblastoma in elderly patients.
Behm T; Horowski A; Schneider S; Bock HC; Mielke D; Rohde V; Stockhammer F
Clin Neurol Neurosurg; 2013 Oct; 115(10):2142-6. PubMed ID: 23993314
[TBL] [Abstract][Full Text] [Related]
10. Managing Glioblastoma in the Elderly Patient: New Opportunities.
Snyder J; Walbert T
Oncology (Williston Park); 2017 Jun; 31(6):476-83. PubMed ID: 28620898
[TBL] [Abstract][Full Text] [Related]
11. Local delivery of angiogenesis-inhibitor minocycline combined with radiotherapy and oral temozolomide chemotherapy in 9L glioma.
Bow H; Hwang LS; Schildhaus N; Xing J; Murray L; Salditch Q; Ye X; Zhang Y; Weingart J; Brem H; Tyler B
J Neurosurg; 2014 Mar; 120(3):662-9. PubMed ID: 24359008
[TBL] [Abstract][Full Text] [Related]
12. Early necrosis following concurrent Temodar and radiotherapy in patients with glioblastoma.
Chamberlain MC; Glantz MJ; Chalmers L; Van Horn A; Sloan AE
J Neurooncol; 2007 Mar; 82(1):81-3. PubMed ID: 16944309
[TBL] [Abstract][Full Text] [Related]
13. [Glioblastoma in the elderly].
Delattre JY
Rev Neurol (Paris); 2011 Oct; 167(10):680-2. PubMed ID: 21890157
[TBL] [Abstract][Full Text] [Related]
14. Prospective study of carmustine wafers in combination with 6-month metronomic temozolomide and radiation therapy in newly diagnosed glioblastoma: preliminary results.
Salmaggi A; Milanesi I; Silvani A; Gaviani P; Marchetti M; Fariselli L; Solero CL; Maccagnano C; Casali C; Guzzetti S; Pollo B; Ciusani E; Dimeco F
J Neurosurg; 2013 Apr; 118(4):821-9. PubMed ID: 23350777
[TBL] [Abstract][Full Text] [Related]
15. Adding concomitant and adjuvant temozolomide to radiotherapy does not reduce health-related quality of life in people with glioblastoma.
Hamilton DA
Cancer Treat Rev; 2006 Oct; 32(6):483-6. PubMed ID: 16730911
[No Abstract] [Full Text] [Related]
16. Glioblastoma in the elderly: initial management.
de Moraes FY; Laperriere N
Chin Clin Oncol; 2017 Aug; 6(4):39. PubMed ID: 28841801
[TBL] [Abstract][Full Text] [Related]
17. Can we afford to add chemotherapy to radiotherapy for glioblastoma multiforme? Cost-identification analysis of concomitant and adjuvant treatment with temozolomide until patient death.
Wasserfallen JB; Ostermann S; Pica A; Mirimanoff RO; Leyvraz S; Villemure JG; Stupp R
Cancer; 2004 Nov; 101(9):2098-105. PubMed ID: 15389472
[TBL] [Abstract][Full Text] [Related]
18. Current and Future Drug Treatments for Glioblastomas.
Ohba S; Hirose Y
Curr Med Chem; 2016; 23(38):4309-4316. PubMed ID: 27758718
[TBL] [Abstract][Full Text] [Related]
19. [Bevacizumab associated with radiotherapy and temozolomide as a first line treatment for high-grade gliomas: one answer but too many questions].
Lebrun-Frenay C
Rev Neurol (Paris); 2014 Apr; 170(4):235-6. PubMed ID: 24776742
[No Abstract] [Full Text] [Related]
20. O(6) -methylguanine-DNA methyltransferase (MGMT) promoter methylation and low MGMT-encoded protein expression as prognostic markers in glioblastoma patients treated with biodegradable carmustine wafer implants after initial surgery followed by radiotherapy with concomitant and adjuvant temozolomide.
Lechapt-Zalcman E; Levallet G; Dugué AE; Vital A; Diebold MD; Menei P; Colin P; Peruzzy P; Emery E; Bernaudin M; Chapon F; Guillamo JS
Cancer; 2012 Sep; 118(18):4545-54. PubMed ID: 22359215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
